Table 1.
Alterations of mycobiome in liver diseases.
| Liver disease | Design and participant details | Methodology | Fungal diversity | Mycobiota composition | Reference | ||
|---|---|---|---|---|---|---|---|
| Family | genus | species | |||||
| Alcohol-associated Liver Disease | Healthy individuals (controls, n=8) Alcohol use disorder patients without progressive liver disease (n=10) Alcohol-associated hepatitis patients (n=6) Alcohol-associated liver cirrhosis patients (n= 4) |
ITS1 |
|
Candida ↑
Epicoccum ↓ Galactomyces ↓ Debaryomyces ↓ |
[17] | ||
| Alcohol-associated Liver Disease | Alcohol-associated hepatitis (n=59) Alcohol use disorder (n=15) Healthy controls (n=11) |
ITS1 |
|
Candida ↑
Penicillium ↓ |
[18] | ||
| Alcohol-associated Liver Disease | Non-alcoholic controls (n=11) Alcohol use disorder (n=42) Alcohol-associated hepatitis (n=91) |
Culture and single colony qPCR | Not reported | Candida albicans ↑ | [19] | ||
| Alcohol-associated Disease | Healthy control subjects (n=18) Alcohol use disorder (n=66) |
ITS2 | Not reported |
Cystostereaceae ↑
Debaryomycetaceae ↑ Didymellaceae ↑ Microascaceae ↑ Pichiae ↑ |
Candida ↑
Debaryomyces ↑ Pichia ↑ Kluyveromyces ↑ Issatchenkia ↑ Scopulariopsis ↑ Aspergillus ↓ |
Candida albicans ↑
Candida zeylanoides ↑ Issatchenkia orientalis ↑ Scopulariopsis cordiae ↑ Kazachstania humilis ↓ |
[20] |
| Nonalcoholic fatty liver disease | NAFLD (n=78; 24 NAFL, 54 NASH; 40 F0-F1, 38 F2-F4) Controls (n=16) | ITS2 | No significant difference |
Candida. albicans ↑ Mucor sp. ↑ Cyberlindnera jadinii ↑ Penicillium sp.↑ unknown Pleosporales ↑ Babjeviella inositovora ↑ Candida argentea ↑ log ratio: Babjeviella inositovora/S. cerevisiae ↑ log ratio: Mucor sp./S. cerevisiae ↑ log ratio: unknown Hanseniaspora/S. cerevisiae ↑ |
[23] | ||
| Nonalcoholic fatty liver disease | NAFLD patients(n=79) healthy subjects (n=34) |
ITS |
Talaromyces ↑ Paraphaeosphaeria ↑ Lycoperdon ↑ Curvularia ↑ Phialemoniopsis ↑ Paraboeremia ↑ Sarcinomyces ↑ Cladophialophora ↑ Sordaria ↑ Leptosphaeria ↓ Pseudopithomyces ↓ Fusicolla ↓ |
[24] | |||
| Primary sclerosing cholangitis | PSC with IBD (n=27) PSC without IBD (n=22) IBD without PSC (n=33) Healthy subjects (n=30). |
ITS2 | No significant difference | Exophiala ↑ | Saccharomyces. cerevisiae ↓ | [26] | |
| Primary sclerosing cholangitis | Healthy subjects (n=66) PSC patients (n=65, n=32 (PSC-IBD) Ulcerative colitis patients (n=38) |
PCR ITS2 | No significant difference |
Candida ↑
Humicola ↑ |
Hamataliwa.grisea ↑ | [27] | |
| Cirrhosis | Cross-sectional analysis: Cirrhosis (n=143, 77 outpatients, 66 inpatients) Healthy controls (n=26) Three Longitudinal studies: 1) cirrhotics followed over 6 months 2) outpatient cirrhotics with antibiotics for 5 days 3) cirrhotics and controls administered omeprazole over 14 days |
ITS1 |
|
Candida ↑ | [28] | ||
| Cirrhosis | Liver cirrhosis patients (n=135, blood n = 135, ascites n = 92, duodenal fluid n = 54) Healthy control (n=26, blood n = 26, duodenal fluid n = 26) |
PCR- and culture-based techniques | Not reported | Candida ↑ | [29] | ||
| Hepatitis B virus | Hepatitis B cirrhosis (n=38) Chronic hepatitis B (n=35) HBV carriers (n=33) Healthy volunteers (n=55). |
Culture, PCR | Patients with hepatitis B cirrhosis > patients with chronic hepatitis B >HBV carriers ≈ healthy volunteers. |
Candida ↑
Saccharomyces ↑ Aspergillus ↑ Galactomyces ↑ Chaetomium ↑ |
Aspergillus versicolor ↑
Aspergillus penicillioides ↑ Candida. solani ↑ Candida. albicans ↑ Candida. tropicalis ↑ Saccharomyces sp. ↑ Saccharomyces. cerevisiae ↑ Chaetomium sp. ↑ Wallemia muriae ↑ Asterotremella albida ↑ Rhizopus microsporus var. ↑ |
[31] | |
| Cirrhosis Hepatitis B virus | Hepatitis B patients (n=52) Hepatitis B patients with cirrhosis (n=52) Healthy controls (n=40) |
Culture | Not reported | Saccharomyces ↑ | [32] | ||
| Hepatitis B virus | HBV-liver cirrhosis patients (n=80) Chronic hepatitis B patients (n=68) HBV carriers (n=66) Healthy volunteers (n=84) |
QPCR |
C.parapsilosis ↑
C. glabrata ↑ C. tropicalis S. cerevisiae ↑ |
[33] | |||
| Hepatitis C Virus | Patients with chronic HCV infection (n=26) HCV cirrhosis (n=26) Healthy control (n=55) |
Culture, PCR | Not reported | Candida ↑ | [34] | ||